These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33663231)

  • 1. Could a Low-Dose Diuretic Polypill Improve Outcomes in Heart Failure With Preserved Ejection Fraction?
    Khan SS; Huffman MD; Shah SJ
    Circ Heart Fail; 2021 Mar; 14(3):e008090. PubMed ID: 33663231
    [No Abstract]   [Full Text] [Related]  

  • 2. Improving Care for Heart Failure With Reduced Ejection Fraction-A Potential Polypill-Based Strategy.
    Agarwal A; Yancy CW; Huffman MD
    JAMA; 2020 Dec; 324(22):2259-2260. PubMed ID: 33211084
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diuretic therapy in acute heart failure].
    Trullàs JC; Morales-Rull JL; Formiga F
    Med Clin (Barc); 2014 Mar; 142 Suppl 1():36-41. PubMed ID: 24930082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction.
    Ter Maaten JM; Martens P; Damman K; Dickstein K; Ponikowski P; Lang CC; Ng LL; Anker SD; Samani NJ; Filippatos G; Cleland JG; Zannad F; Hillege HL; van Veldhuisen DJ; Metra M; Voors AA; Mullens W
    Clin Res Cardiol; 2020 Aug; 109(8):1048-1059. PubMed ID: 32002631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of natriuretic-doses of spironolactone for treatment of loop diuretic resistant acute decompensated heart failure.
    Eng M; Bansal S
    Int J Cardiol; 2014 Jan; 170(3):e68-9. PubMed ID: 24268982
    [No Abstract]   [Full Text] [Related]  

  • 6. Loop Diuretic Use and Outcomes in Chronic Stable Heart Failure With Preserved Ejection Fraction-Reply.
    Rao VN; Pandey A; Zhong L; Ambrosy AP; Fudim M
    Mayo Clin Proc; 2021 Feb; 96(2):503-506. PubMed ID: 33549271
    [No Abstract]   [Full Text] [Related]  

  • 7. Outcomes Associated With a Strategy of Adjuvant Metolazone or High-Dose Loop Diuretics in Acute Decompensated Heart Failure: A Propensity Analysis.
    Brisco-Bacik MA; Ter Maaten JM; Houser SR; Vedage NA; Rao V; Ahmad T; Wilson FP; Testani JM
    J Am Heart Assoc; 2018 Sep; 7(18):e009149. PubMed ID: 30371181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal and Cardiovascular Effects of SGLT2 Inhibition in Combination With Loop Diuretics in Patients With Type 2 Diabetes and Chronic Heart Failure: The RECEDE-CHF Trial.
    Mordi NA; Mordi IR; Singh JS; McCrimmon RJ; Struthers AD; Lang CC
    Circulation; 2020 Nov; 142(18):1713-1724. PubMed ID: 32865004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of loop diuretics with thiazide-type diuretics in heart failure.
    Jentzer JC; DeWald TA; Hernandez AF
    J Am Coll Cardiol; 2010 Nov; 56(19):1527-34. PubMed ID: 21029871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with acute heart failure treated with the CARRESS-HF diuretic protocol in association with canrenoate potassium: Tolerance of high doses of canrenoate potassium.
    Berger C; Prieur C; Bochaton T; Berthiller J; Luyt CE; Bonnefoy-Cudraz E
    Arch Cardiovasc Dis; 2020 Nov; 113(11):679-689. PubMed ID: 32948466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced Diuretic Dose in Patients Treated With Eplerenone: Data From the EPHESUS Trial.
    Ferreira JP; Eschalier R; Duarte K; Damman K; Gustafsson F; Schou M; Girerd N; Fay R; Tala S; Pitt B; Zannad F; Rossignol P
    Circ Heart Fail; 2020 May; 13(5):e006597. PubMed ID: 32354280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining loop with thiazide diuretics in patients discharged home after a heart failure decompensation: Association with 30-day outcomes.
    Miró Ò; Núñez J; Trullàs JC; Lopez-Ayala P; Llauger L; Alquézar-Arbé A; Miñana G; Mollar A; de la Espriella R; Lorenzo M; Jacob J; Espinosa B; Garcés-Horna V; Aguirre A; Fortuny MJ; Martínez-Nadal G; Gil V; Mueller C; Llorens P; ; ;
    Eur J Intern Med; 2024 Sep; 127():126-133. PubMed ID: 38763846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload: EMPEROR-Reduced Trial.
    Packer M; Anker SD; Butler J; Filippatos G; Ferreira JP; Pocock SJ; Sattar N; Brueckmann M; Jamal W; Cotton D; Iwata T; Zannad F;
    J Am Coll Cardiol; 2021 Mar; 77(11):1381-1392. PubMed ID: 33736819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of diuretics in heart failure with preserved ejection fraction: a scoping review.
    Singh A; Agarwal A; Wafford QE; Shah SJ; Huffman M; Khan S
    Heart; 2022 Apr; 108(8):593-605. PubMed ID: 34340995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diuretics and ultrafiltration in acute decompensated heart failure.
    Felker GM; Mentz RJ
    J Am Coll Cardiol; 2012 Jun; 59(24):2145-53. PubMed ID: 22676934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM-HF trial.
    Vardeny O; Claggett B; Kachadourian J; Desai AS; Packer M; Rouleau J; Zile MR; Swedberg K; Lefkowitz M; Shi V; McMurray JJV; Solomon SD
    Eur J Heart Fail; 2019 Mar; 21(3):337-341. PubMed ID: 30741494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity-Related Heart Failure With a Preserved Ejection Fraction: The Mechanistic Rationale for Combining Inhibitors of Aldosterone, Neprilysin, and Sodium-Glucose Cotransporter-2.
    Packer M; Kitzman DW
    JACC Heart Fail; 2018 Aug; 6(8):633-639. PubMed ID: 29525327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous Diuretic Therapy for the Management of Heart Failure and Volume Overload in a Multidisciplinary Outpatient Unit.
    Buckley LF; Carter DM; Matta L; Cheng JW; Stevens C; Belenkiy RM; Burpee LJ; Young MA; Weiffenbach CS; Smallwood JA; Stevenson LW; Desai AS
    JACC Heart Fail; 2016 Jan; 4(1):1-8. PubMed ID: 26656139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spironolactone discontinuation in patients with heart failure: complex interactions with loop diuretics. Letter regarding the article 'Spironolactone dose in heart failure with preserved ejection fraction: findings from TOPCAT'.
    Čulić V; Velat I
    Eur J Heart Fail; 2021 Jan; 23(1):198-199. PubMed ID: 33094888
    [No Abstract]   [Full Text] [Related]  

  • 20. [Value of aldosterone receptor blockade in diuretic therapy of patients with chronic heart failure].
    Christ M; Ludwig N; Maisch B
    Herz; 2002 Mar; 27(2):135-49. PubMed ID: 12025459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.